Regeneron Pharmaceuticals (REGN)
Capital Expenditure
-$240.20M
Quarterly · Period ending: · USD
REGN Capital Expenditure
Latest reported-$240.20Mperiod ending
Latest reported-$240.20Mperiod ending
REGN Quarterly CapEx (-$100.00K → -$240.20M)
Quarterly CapEx
High-resolution chart · PNG
REGN capital expenditure history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -240,200,000 | |
| -230,600,000 | |
| -248,700,000 | |
| -201,400,000 | |
| -176,800,000 | |
| -271,500,000 | |
| -267,000,000 | |
| -183,600,000 | |
| -210,900,000 | |
| -161,800,000 | |
| -313,500,000 | |
| -176,000,000 | |
| -113,000,000 | |
| -178,200,000 | |
| -152,200,000 | |
| -142,500,000 | |
| -153,600,000 | |
| -141,800,000 | |
| -154,900,000 | |
| -133,200,000 | |
| -148,500,000 | |
| -115,300,000 | |
| -161,400,000 | |
| -153,200,000 | |
| -129,900,000 | |
| -170,100,000 | |
| -139,000,000 | |
| -121,700,000 | |
| -94,600,000 | |
| -74,300,000 | |
| -85,500,000 | |
| -106,200,000 | |
| -112,000,000 | |
| -79,400,000 | |
| -107,637,000 | |
| -59,653,000 | |
| -54,849,000 | |
| -50,461,000 | |
| -150,455,000 | |
| -118,556,000 | |
| -138,836,000 | |
| -104,094,000 | |
| -177,779,000 | |
| -146,099,000 | |
| -239,893,000 | |
| -114,162,000 | |
| -117,542,000 | |
| -79,769,000 | |
| -70,873,000 | |
| -64,822,000 | |
| -68,976,000 | |
| -31,691,000 | |
| -34,453,000 | |
| -21,203,000 | |
| -15,162,000 | |
| -10,248,000 | |
| -12,872,000 | |
| -11,055,000 | |
| -11,289,000 | |
| -8,898,000 | |
| -14,864,000 | |
| -22,166,000 | |
| -32,262,000 | |
| -22,103,000 | |
| -22,581,000 | |
| -22,743,000 | |
| -22,316,000 | |
| -22,331,000 | |
| -30,754,000 | |
| -21,917,000 | |
| -15,740,000 | |
| -9,328,000 | |
| -6,742,000 | |
| -3,047,000 | |
| -10,730,000 | |
| -4,692,000 | |
| -1,827,000 | |
| -1,197,000 | |
| -1,208,000 | |
| -617,000 | |
| -340,000 | |
| -646,000 | |
| -351,000 | |
| -1,716,000 | |
| -1,538,000 | |
| -1,359,000 | |
| -1,327,000 | |
| -2,314,000 | |
| -1,548,000 | |
| -985,000 | |
| -1,285,000 | |
| -3,386,000 | |
| -4,981,000 | |
| -20,004,000 | |
| -15,171,000 | |
| -8,318,000 | |
| -6,881,000 | |
| -4,000,000 | |
| -2,600,000 | |
| -1,767,000 |